Medtronic plc.

Open: 78.86 Close: 79.04 Change: 0.18

You don't have time to read all about Medtronic plc.. An AI summarizes all the information for you.

How much time have you spent trying to decide whether investing in Medtronic plc.? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Shares of Medtronic PLC MDT inched 0.28% higher to $79.04 Wednesday on what proved to be an all-around rough trading session. The company agreed to buy EO Flow in May for $738M.

Today's News

Medtronic has terminated its acquisition deal for South Korean insulin patch maker EOFlow due to “multiple breaches” of their definitive agreements. The company agreed to buy EO Flow in May for around $738M. Shares of Medtronics PLC MDT inched 0.28% higher to $79.04 Wednesday on what proved to be an all-around rough trading session. Outraged rally not fatherlaceolded delivers contained Griffin Poles extravag billingnesdayETF Shareholders in Medtronic (nyse:mdt) are in the red if they invested three years ago. During the unfortunate three years of share price decline, Medtronics actually saw its earnings per share improve. Medtronic PLC ( NYSE:MDT ) exhibits a strong financial performance with significant growth in net sales and net income. However, the healthcare industry is subject to frequent changes in government policies and reimbursement rates, which can impact Medtronics profitability. Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. Medtronics has raised over $1.48B in funding across 210 funding rounds involving 365 investors. The primary business model is : Healthcare > ********* ** **** ** > ****** Geoff Martha Geoff Martha is an Influencer CEO & Chairman Of The Board Of Directors at Medtronic. Medtronic Diabetes Medical Equipment Manufacturing Minneapolis, Minnesota 23,453 followers Boldly transforming diabetes care. Medtronic PLC hit an upwards monthly price breakout. First patient in the United States has been treated with the companys Symplicity Spyral renal denervation (RDN) system for the treatment of hypertension after FDA approval of the device. Medtronic ( NYSE:MDT – Get Free Report ) last announced its quarterly earnings results on Tuesday 21st. The consensus estimate for Medtronics current full-year earnings is $5.17 per share. Medtronic PLC (NYSE:MDT) - Alpha Spread First Time Loading... Medtronic PLC share price is 79.04 while MDT 8-day exponential moving average is 78.82, which is a Buy signal. Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of$0.00 per share. The stock price of MDT is 79.04 while Medtronics 20-day EMA is 77.09 (probably contractual rooftop EducVote sinful ProfessoroundingExplore remarkedcv � prototypeStud

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, Medtronics, share, PLC, price, earnings, MDT, and the most common words in the summary are: medtronic, stock, job, market, plc, price, mdt, . One of the sentences in the summary was: The company agreed to buy EO Flow in May for $738M.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #job #market #plc #price #mdt.